Table 2

Visit Metrics

ParameterAll Patients
(N = 60)
HFrEF
(n = 36)
HFpEF
(n = 24)
No. of visits
 133 (55)22 (61.1)11 (45.8)
 215 (25)9 (25)6 (25)
 ≥312 (20)5 (13.9)7 (29.2)
Duration between first and second visits, days6 (4–13)6 (4–14)6 (5–13)
Duration between second and third visits, days7 (4–27)7 (4–44)5 (3–9)
Diuretic therapy
 Total dose, mg260 (140–260)250 (140–260)240 (130–260)
 Low-dose group11 (18.3)5 (13.9)6 (25)
 Standard-dose group13 (21.7)7 (19.4)6 (25)
 High-dose group7 (11.7)6 (16.7)1 (4.2)
 Mega-dose group29 (48.3)18 (50)11 (45.8)
Time to laboratory follow-up, days3 (1–4)3 (1–3)3 (2–4)

Values are n (%) or median (interquartile range).

Abbreviations as in Table 1.

  • Milligrams of intravenous furosemide per visit.